---
figid: PMC9630603__fbioe-10-1005051-g004
pmcid: PMC9630603
image_filename: fbioe-10-1005051-g004.jpg
figure_link: /pmc/articles/PMC9630603/figure/F4/
number: FIGURE 4
figure_title: ''
caption: Potential Therapeutic strategies for fibrosis. (A) Anti-fibrotic therapeutic
  strategies through inhibition of TGF-Î² pathway. (B) Therapeutic strategies through
  inhibition of RAS system. (C) Targeted anti-fibrotic therapeutic approach through
  biomaterial-based delivery. (D) Stem cell therapy with mesenchymal stromal cells
  for the treatment of fibrotic disease. (E) CAR T-cell therapy using engineered T
  cells for the treatment of fibrotic disease. (F) Gene therapy through mediating
  miRNA as a novel approach for anti-fibrosis treatment.
article_title: Intersection of stem cell biology and engineering towards next generation
  in vitro models of human fibrosis.
citation: Erika Yan Wang, et al. Front Bioeng Biotechnol. 2022;10:1005051.
year: '2022'

doi: 10.3389/fbioe.2022.1005051
journal_title: Frontiers in Bioengineering and Biotechnology
journal_nlm_ta: Front Bioeng Biotechnol
publisher_name: Frontiers Media S.A.

keywords:
- tissue engineeering
- stem cell
- fibrosis
- disease modeling
- organ on a chip (OCC)
- biosensor
- machine learning (ML)

---
